MBX MBX Biosciences, Inc. Common Stock
Healthcare$31.75-0.31%ClosedMarket Cap: $1.07B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$60.33
Target (Median)
$65.00
Target Range
$18.00 - $88.00
Upside from current price: 90.0%
Rating Distribution
2 Strong Buy9 Buy0 Hold1 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-12 | Barclays | maintain | Overweight | Overweight |
| 2026-05-12 | Citizens | maintain | Market Outperform | Market Outperform |
| 2026-05-11 | Truist Securities | maintain | Buy | Buy |
| 2026-01-16 | Guggenheim | maintain | Buy | Buy |
| 2025-12-19 | Stifel | maintain | Buy | Buy |
| 2025-11-10 | Guggenheim | maintain | Buy | Buy |
| 2025-09-24 | Mizuho | maintain | Outperform | Outperform |
| 2025-09-23 | Guggenheim | maintain | Buy | Buy |
| 2025-09-23 | Oppenheimer | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-3.91 | $0.00 | 8 |
| Sun Dec 31 | $-4.17 | $23.5M | 7 |
| Mon Dec 31 | $-3.03 | $130.4M | 2 |
| Tue Dec 31 | $-0.60 | $351.3M | 5 |